ALICR.PA
I.CERAM SA [ALICR.PA] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ALICR.PA Stock Summary
In the News
ALICR.PA Financial details
Company Rating
-
Market Cap
350.73K
Income
-717.19K
Revenue
2.75M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
25
Optionable
No
Shortable
Yes
Earnings
02 Apr 2024
P/E
-0.96
Forward P/E
-
PEG
1.34
P/S
0.64
P/B
0.44
P/C
-
P/FCF
-1.05
Quick Ratio
0.01
Current Ratio
2.95
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-2.45
EPS next Y
-
EPS next Q
-
EPS this Y
21.59%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-18.63%
Revenue last 5Y
-1.14%
Revenue Q/Q
21.38%
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-19%
ROE
-48%
ROC
-0.22%
Gross Margin
9%
Oper. Margin
-62%
Profit Margin
-67%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1.18-9.5
52W High
-95.53%
52W Low
-59.8%
RSI
15
Rel Volume
1.38
Avg Volume
811
Volume
1.12K
Perf Week
0%
Perf Month
-10.27%
Perf Quarter
-
Perf Half Y
-14.47%
-
-
-
-
Beta
1.155
-
-
Volatility
0%, 0.02%
Prev Close
0%
Price
0.402
Change
0%
Company Profile
- Volume Average 811
- Market Capitalization 350.73K
- Employee 25
- CEO Mr. André Kérisit
- Headquarters Limoges,FR
- IPO Date 2014-12-19
-
Website
https://www.iceram.fr 
I.CERAM SA designs, manufactures, and markets alumina-based ceramic implants in France and internationally. It offers implants for various joints of the human body, including skull, shoulder, spine, hip, tibia, ankle, foot, and thorax, as well as osteosynthesis products. The company was founded in 2005 and is headquartered in Limoges, France. I.CERAM SA is a subsidiary of Investissement Développement.
